Literature DB >> 33765049

ICU outcomes and survival in patients with severe COVID-19 in the largest health care system in central Florida.

Eduardo Oliveira1, Amay Parikh1, Arnaldo Lopez-Ruiz1, Maria Carrilo1, Joshua Goldberg1, Martin Cearras1, Khaled Fernainy1, Sonja Andersen1, Luis Mercado2, Jian Guan2, Hammad Zafar2, Patricia Louzon3, Amy Carr3, Natasha Baloch1, Richard Pratley4, Scott Silverstry5, Vincent Hsu6, Jason Sniffen6, Victor Herrera6, Neil Finkler7.   

Abstract

BACKGROUND: Observational studies have consistently described poor clinical outcomes and increased ICU mortality in patients with severe coronavirus disease 2019 (COVID-19) who require mechanical ventilation (MV). Our study describes the clinical characteristics and outcomes of patients with severe COVID-19 admitted to ICU in the largest health care system in the state of Florida, United States.
METHODS: Retrospective cohort study of patients admitted to ICU due to severe COVID-19 in AdventHealth health system in Orlando, Florida from March 11th until May 18th, 2020. Patients were characterized based on demographics, baseline comorbidities, severity of illness, medical management including experimental therapies, laboratory markers and ventilator parameters. Major clinical outcomes analyzed at the end of the study period were: hospital and ICU length of stay, MV-related mortality and overall hospital mortality of ICU patients.
RESULTS: Out of total of 1283 patients with COVID-19, 131 (10.2%) met criteria for ICU admission (median age: 61 years [interquartile range (IQR), 49.5-71.5]; 35.1% female). Common comorbidities were hypertension (84; 64.1%), and diabetes (54; 41.2%). Of the 131 ICU patients, 109 (83.2%) required MV and 9 (6.9%) received ECMO. Lower positive end expiratory pressure (PEEP) were observed in survivors [9.2 (7.7-10.4)] vs non-survivors [10 (9.1-12.9] p = 0.004]. Compared to non-survivors, survivors had a longer MV length of stay (LOS) [14 (IQR 8-22) vs 8.5 (IQR 5-10.8) p< 0.001], Hospital LOS [21 (IQR 13-31) vs 10 (7-1) p< 0.001] and ICU LOS [14 (IQR 7-24) vs 9.5 (IQR 6-11), p < 0.001]. The overall hospital mortality and MV-related mortality were 19.8% and 23.8% respectively. After exclusion of hospitalized patients, the hospital and MV-related mortality rates were 21.6% and 26.5% respectively.
CONCLUSIONS: Our study demonstrates an important improvement in mortality of patients with severe COVID-19 who required ICU admission and MV in comparison to previous observational reports and emphasizes the importance of standard of care measures in the management of COVID-19.

Entities:  

Mesh:

Year:  2021        PMID: 33765049      PMCID: PMC7993561          DOI: 10.1371/journal.pone.0249038

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


  37 in total

Review 1.  Past and Present ARDS Mortality Rates: A Systematic Review.

Authors:  Jan Máca; Ondřej Jor; Michal Holub; Peter Sklienka; Filip Burša; Michal Burda; Vladimír Janout; Pavel Ševčík
Journal:  Respir Care       Date:  2016-11-01       Impact factor: 2.258

2.  Prone positioning in severe acute respiratory distress syndrome.

Authors:  Claude Guérin; Jean Reignier; Jean-Christophe Richard; Pascal Beuret; Arnaud Gacouin; Thierry Boulain; Emmanuelle Mercier; Michel Badet; Alain Mercat; Olivier Baudin; Marc Clavel; Delphine Chatellier; Samir Jaber; Sylvène Rosselli; Jordi Mancebo; Michel Sirodot; Gilles Hilbert; Christian Bengler; Jack Richecoeur; Marc Gainnier; Frédérique Bayle; Gael Bourdin; Véronique Leray; Raphaele Girard; Loredana Baboi; Louis Ayzac
Journal:  N Engl J Med       Date:  2013-05-20       Impact factor: 91.245

3.  The Surviving Sepsis Campaign Bundle: 2018 update.

Authors:  Mitchell M Levy; Laura E Evans; Andrew Rhodes
Journal:  Intensive Care Med       Date:  2018-04-19       Impact factor: 17.440

4.  COVID-19 and African Americans.

Authors:  Clyde W Yancy
Journal:  JAMA       Date:  2020-05-19       Impact factor: 56.272

5.  Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy.

Authors:  Giacomo Grasselli; Alberto Zangrillo; Alberto Zanella; Massimo Antonelli; Luca Cabrini; Antonio Castelli; Danilo Cereda; Antonio Coluccello; Giuseppe Foti; Roberto Fumagalli; Giorgio Iotti; Nicola Latronico; Luca Lorini; Stefano Merler; Giuseppe Natalini; Alessandra Piatti; Marco Vito Ranieri; Anna Mara Scandroglio; Enrico Storti; Maurizio Cecconi; Antonio Pesenti
Journal:  JAMA       Date:  2020-04-28       Impact factor: 56.272

6.  Incidence, clinical outcomes, and transmission dynamics of severe coronavirus disease 2019 in California and Washington: prospective cohort study.

Authors:  Joseph A Lewnard; Vincent X Liu; Michael L Jackson; Mark A Schmidt; Britta L Jewell; Jean P Flores; Chris Jentz; Graham R Northrup; Ayesha Mahmud; Arthur L Reingold; Maya Petersen; Nicholas P Jewell; Scott Young; Jim Bellows
Journal:  BMJ       Date:  2020-05-22

7.  Treatment With Convalescent Plasma for Critically Ill Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Infection.

Authors:  Bin Zhang; Shuyi Liu; Tan Tan; Wenhui Huang; Yuhao Dong; Luyan Chen; Qiuying Chen; Lu Zhang; Qingyang Zhong; Xiaoping Zhang; Yujian Zou; Shuixing Zhang
Journal:  Chest       Date:  2020-03-31       Impact factor: 9.410

8.  Convalescent plasma as a potential therapy for COVID-19.

Authors:  Long Chen; Jing Xiong; Lei Bao; Yuan Shi
Journal:  Lancet Infect Dis       Date:  2020-02-27       Impact factor: 25.071

9.  No evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe COVID-19 infection.

Authors:  J M Molina; C Delaugerre; J Le Goff; B Mela-Lima; D Ponscarme; L Goldwirt; N de Castro
Journal:  Med Mal Infect       Date:  2020-03-30       Impact factor: 2.152

10.  COVID-19 pulmonary pathology: a multi-institutional autopsy cohort from Italy and New York City.

Authors:  Alain C Borczuk; Fiorella Calabrese; Mary Beth Beasley; Steven P Salvatore; Surya V Seshan; Sanjay S Patel; James B Bussel; Maria Mostyka; Sarah Elsoukkary; Bing He; Claudia Del Vecchio; Francesco Fortarezza; Federica Pezzuto; Paolo Navalesi; Andrea Crisanti; Mary E Fowkes; Clare H Bryce
Journal:  Mod Pathol       Date:  2020-09-02       Impact factor: 7.842

View more
  35 in total

1.  Predictors for adult COVID-19 hospitalized inpatient mortality rate in North West Ethiopia.

Authors:  Fassikaw Kebede; Tsehay Kebede; Tilahun Gizaw
Journal:  SAGE Open Med       Date:  2022-03-04

2.  Factors Associated for COVID19 Severity Among Patients Treated at Selgalu Treatment Center Assosa in Ethiopia: A Case-Control Study.

Authors:  Dano Gutata; Zewdie Aderaw Alemu
Journal:  Int J Gen Med       Date:  2022-03-24

3.  SCD14-ST and New Generation Inflammatory Biomarkers in the Prediction of COVID-19 Outcome.

Authors:  Emanuela Galliera; Luca Massaccesi; Lina Yu; Jianwen He; Marco Ranucci; Massimiliano M Corsi Romanelli
Journal:  Biomolecules       Date:  2022-06-13

4.  Association of Obesity With COVID-19 Severity and Mortality: An Updated Systemic Review, Meta-Analysis, and Meta-Regression.

Authors:  Romil Singh; Sawai Singh Rathore; Hira Khan; Smruti Karale; Yogesh Chawla; Kinza Iqbal; Abhishek Bhurwal; Aysun Tekin; Nirpeksh Jain; Ishita Mehra; Sohini Anand; Sanjana Reddy; Nikhil Sharma; Guneet Singh Sidhu; Anastasios Panagopoulos; Vishwanath Pattan; Rahul Kashyap; Vikas Bansal
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-03       Impact factor: 6.055

5.  Characterization and Determinant Factors of Critical Illness and In-Hospital Mortality of COVID-19 Patients: A Retrospective Cohort of 1792 Patients in Kenya.

Authors:  Isinta M Elijah; Endawoke Amsalu; Xuening Jian; Mingyang Cao; Eric K Mibei; Danvas O Kerosi; Francis G Mwatsahu; Wei Wang; Faith Onyangore; Youxin Wang
Journal:  Biosaf Health       Date:  2022-06-27

6.  Neurologic manifestations of COVID-19 in critically ill patients: results of the prospective multicenter registry PANDEMIC.

Authors:  Konstantinos Dimitriadis; Jan Meis; Hermann Neugebauer; Kristian Barlinn; Bernhard Neumann; Georg Gahn; Piergiorgio Lochner; Benjamin Knier; Sarah Lindemann; Kurt Wolfram Sühs; Kristina Szabo; Thomas Pfefferkorn; Ingo Schirotzek; Tobias Freilinger; Bassa Burc; Albrecht Günther; Matthias Wittstock; Patrick Schramm; Gernot Reimann; Jana Godau; Gabor Nagy; Fatima B Koenig; Fabian Essig; Hartwig Klinker; Christian Hartmann; Moritz L Schmidbauer; Tim Steinberg; Lora Lefterova; Christina Klose; Julian Bösel
Journal:  Crit Care       Date:  2022-07-16       Impact factor: 19.334

7.  Clinicodemographic profile, intensive care unit utilization and mortality rate among COVID-19 patients admitted during the second wave in Bangladesh.

Authors:  Sultana Parvin; Md Samiul Islam; Touhidul Karim Majumdar; Faruque Ahmed
Journal:  IJID Reg       Date:  2021-12-03

Review 8.  Characteristics and Outcomes of Patients With Frailty Admitted to ICU With Coronavirus Disease 2019: An Individual Patient Data Meta-Analysis.

Authors:  Ashwin Subramaniam; Christopher Anstey; J Randall Curtis; Sushma Ashwin; Mallikarjuna Ponnapa Reddy; Márlon Juliano Romero Aliberti; Thiago Junqueira Avelino-Silva; Carly Welch; Gouri Koduri; John R Prowle; Yize I Wan; Michaël R Laurent; Alessandra Marengoni; Jun Pei Lim; David Pilcher; Kiran Shekar
Journal:  Crit Care Explor       Date:  2022-01-18

9.  Critical Illness in COVID-19: A Sobering Experience for the Intensivist.

Authors:  Bhuvana Krishna
Journal:  Indian J Crit Care Med       Date:  2021-09

Review 10.  The snapshot of metabolic health in evaluating micronutrient status, the risk of infection and clinical outcome of COVID-19.

Authors:  Dimitris Tsoukalas; Evangelia Sarandi; Spyridoula Georgaki
Journal:  Clin Nutr ESPEN       Date:  2021-06-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.